Company Quint Media Inc Other OTC
Equities
US74874T1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharma Services
76.7
%
| - | - | 0 | 76.7 % | - |
Patient Testing Service
23.3
%
| - | - | 0 | 23.3 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +6.85% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Faith Zaslavsky
CEO | Chief Executive Officer | 49 | 22-12-04 |
Director of Finance/CFO | 43 | 08-12-31 | |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Trevor McCartney
IRO | Public Communications Contact | - | 19-02-28 |
Michael Vallone
PRN | Corporate Officer/Principal | - | 23-01-08 |
Mattia Cremona
PRN | Corporate Officer/Principal | - | 22-11-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 20-06-17 |
Michael Ruxin
CTO | Chief Tech/Sci/R&D Officer | 78 | 17-12-31 |
Director of Finance/CFO | 43 | 08-12-31 | |
Danica Holley
BRD | Director/Board Member | 51 | 22-04-03 |
Yvonne Fors
BRD | Director/Board Member | 52 | 20-06-17 |
Matthew Schwartz
BRD | Director/Board Member | 50 | 22-04-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 500 | 0 | 0 | 17.39 % |
Stock B | 0 | 1,000 | 0 | 0 | |
Stock C | 1 | 6,151,499,919 | 1,069,660,735 ( 17.39 %) | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-2.76% | 103B | |
+1.34% | 95.28B | |
+1.46% | 22.15B | |
-15.87% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.33% | 16.05B | |
+4.84% | 13.68B | |
+32.94% | 12.17B |
- Stock Market
- Equities
- THER Stock
- Stock
- Company Quint Media Inc